WG
IMVT icon

Winton Group’s Immunovant IMVT Stock Holding History

Winton Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,675
Closed -$546K – 705
2024
Q2 		$546K Buy
+20,675
New +$588K 0.04% 412
2021
Q4 		– Sell
-47,575
Closed -$413K – 1197
2021
Q3 		$413K Sell
47,575
-3,107
-6% -$28K 0.02% 956
2021
Q2 		$536K Buy
50,682
+26,176
+107% +$365K 0.03% 881
2021
Q1 		$393K Buy
24,506
+17,720
+261% +$467K 0.02% 1008
2020
Q4 		$313K Buy
+6,786
New +$314K 0.02% 1023

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Winton Group's IMVT Position: Q3 2024 in Review

Winton Group sold out of Immunovant (IMVT) in Q3 2024, closing a stake of 20,675 shares — an estimated $546K sold.

Winton Group first reported a position in IMVT in Q4 2020 and held it in 5 quarters. The position peaked at $546K in Q2 2024. 181 funds tracked by Wall St. Rank hold IMVT as of Q3 2024.

  • Winton Group reported no remaining Immunovant position as of Q3 2024 after selling out during the quarter.
  • Winton Group sold 20,675 Immunovant shares in Q3 2024, an estimated $546K.
  • Winton Group first reported a position in Immunovant in Q4 2020 and held it in 5 quarters.
  • Winton Group's Immunovant position peaked at $546K in Q2 2024.
  • 181 funds tracked by Wall St. Rank held Immunovant as of Q3 2024.

Based on Winton Group's 13F filing for Q3 2024, filed 12 Nov 2024.